French startup Ÿnsect shot into the highlight when “Iron Man” star Robert Downey Jr. touted its deserves on the “Late Present” throughout Tremendous Bowl weekend 2021. Now, practically 4 years later, the insect farming firm has been positioned into judicial liquidation — primarily chapter — for insolvency.
The corporate’s demise is hardly a shock, as Ÿnsect had been embattled for months. Nonetheless, there’s loads to unpack about how a startup can go bankrupt regardless of elevating over $600 million, together with from Downey Jr.’s FootPrint Coalition, taxpayers, and lots of others.
In the end, Ÿnsect failed to satisfy its ambition to “revolutionize the meals chain” with insect-based protein. However don’t be too fast to attribute its failure to the “ick” issue that many Westerners really feel about bugs. Human meals was by no means its core focus.
As a substitute, Ÿnsect centered on producing insect protein for animal feed and pet meals, two markets with very completely different economics and margins that the corporate by no means fairly selected between.
That indecision prolonged to its M&A technique. In 2021, Ÿnsect acquired Protifarm, a Dutch firm elevating mealworms for human meals functions, including a 3rd market to the combination. Whilst the corporate introduced the deal, then-CEO Antoine Hubert admitted it will take a few years for human meals to signify simply 10% to fifteen% of Ÿnsect’s income.
“We nonetheless see pet meals and fish feed being the biggest contributor to our revenues within the coming years,” Hubert declared on the time. In different phrases, Ÿnsect was buying an organization in a market phase that might stay marginal for years — at a time when the startup desperately wanted income progress.
And income was the issue. In accordance with publicly out there information, Ÿnsect’s income from its essential entity peaked at €17.8 million in 2021 (roughly $21 million) — a determine reportedly inflated by inside transfers between subsidiaries. By 2023, the corporate had racked up a internet lack of €79.7 million ($94 million).
Techcrunch occasion
San Francisco
|
October 13-15, 2026
So how did an organization with such meager income elevate over $600 million? The reply wasn’t hype-driven crossover funds paying formidable multiples throughout the 2021 funding frenzy. As a substitute, Ÿnsect attracted impact-focused traders like Astanor Ventures and public funding financial institution Bpifrance that purchased right into a compelling sustainability imaginative and prescient.
Its pitch to them was easy — providing an alternative choice to resource-intensive proteins like fishmeal and soy. That very same thesis additionally attracted vital capital to rivals like Higher Origin and Innovafeed, and it appeared promising.
However the imaginative and prescient collided with market actuality. Animal feed is a commodity market pushed by value, not sustainability premiums. In an ideal world, insect protein can be absolutely round, with bugs consumed meals waste that might in any other case go to landfill. However in follow, factory-scale insect manufacturing sometimes finally ends up relying on cereal by-products which might be already usable as animal feed — that means insect protein simply provides an costly further step. For animal feed, the mathematics merely wasn’t working.
Ÿnsect ultimately acknowledged this. Pet meals proved to be a distinct equation: It’s much less price-driven than animal feed and a much better marketplace for insect protein, even with competitors from different different proteins comparable to lab-grown meat. By 2023, the corporate refocused its technique on pet meals and different higher-margin segments, with Hubert citing broader financial pressures.
“In an setting the place there’s inflation on power and uncooked supplies but in addition on the price of capital and debt, we can not afford to speculate a great deal of assets in markets that are the least remunerative (animal feed), when you produce other markets the place there’s quite a lot of demand, good returns and better margins,” Hubert stated on the time.
The 2023 pivot to pet meals got here too late. By then, Ÿnsect had already dedicated to an enormous, capital-intensive guess that might in the end doom the corporate. That guess was Ÿnfarm, a “giga-factory” in Northern France that the corporate billed “the world’s most costly bug farm.” Constructed for insect manufacturing at scale, the power consumed a whole bunch of hundreds of thousands in funding — cash spent earlier than Ÿnsect had confirmed its enterprise mannequin or found out its unit economics.
To supervise Ÿnfarm’s launch, Ÿnsect introduced in Shankar Krishnamoorthy, a former govt at French power large Engie. When that transfer to pet meals failed to avoid wasting the corporate, Krishnamoorthy changed Hubert as CEO.
Ÿnsect then shut down the manufacturing plant it had acquired from Protifarm and lower jobs. However shuttering one facility whereas working a giga-factory constructed for the mistaken market couldn’t remedy the basic downside.
For Professor Joe Haslam, who teaches a course on Scaling Up within the MBA Program at IE Enterprise Faculty, “Ÿnsect’s struggles usually are not a thriller and never primarily about bugs. They’re the results of a mismatch between industrial ambition, capital markets, and timing, compounded by some execution and technique decisions.”
The truth that Ÿnsect failed doesn’t imply the complete insect farming sector is doomed. Competitor Innovafeed is reportedly holding up higher, partially as a result of it began with a smaller manufacturing website and is ramping up incrementally.
For Prof. Haslam, Ÿnsect exemplifies a broader European downside. “Ÿnsect is a case research in Europe’s scaling hole. We fund moonshots. We underfund factories. We have a good time pilots. We abandon industrialization. See Northvolt [a struggling Swedish battery maker], Volocopter [a German air taxi startup], and Lilium [a failed German flying taxi company],” he stated.
The failure has prompted some soul-searching. Hubert himself co-founded Begin Industrie, an affiliation advocating for insurance policies to assist French industrial startups — a recognition that Europe wants extra than simply funding to construct the subsequent technology of deep tech corporations.









